Quidel | QDEL - Le Bénéfice D'Exploitation

Prix De L'Action
17.10
Variation Quotidienne
-0.82 -4.58%
Mensuellement
-26.07%
Annuel
-52.66%
Q1 Prévisions
20.20




Le Bénéfice D'Exploitation Changement Date
Abbott USD 2.25B 73M 2025-12
Agilent USD 353M 90M 2025-12
Avanos Medical USD 24.77M 5.8M 2025-12
Becton, Dickinson and Co. USD 663M 163M 2025-12
Bruker USD 76.3M 7.6M 2025-12
Cerus USD -1.45M 488K 2024-12
Charles River Laboratories USD 75.82M 57.98M 2025-12
Danaher USD 1.5B 348M 2025-12
Exact Sciences USD -25M 22.85M 2025-09
Haemonetics USD 67.4M 8.9M 2025-12
Hologic USD 237M 16M 2025-12
Illumina USD 256M 6M 2025-12
IQVIA Holdings USD 2.68B 2.1B 2025-12
Merit Medical Systems USD 54.2M 11.58M 2025-12
Mettler Toledo International USD 351.93M 57.73M 2025-12
Myriad Genetics USD -23.3M 10.8M 2025-09
Neogen USD -5.38M 10.71M 2025-09
OraSure Technologies USD -6M 3.26M 2024-09
Pacific Biosciences Of California USD -64.08M 111.77M 2024-09
Quidel USD -37.3M 667.5M 2025-12
Revvity USD 145.83M 47.49M 2025-12
STAAR Surgical USD -10.93M 29.42M 2025-12
Thermo Fisher Scientific USD 2.3B 226M 2025-12
Waters USD 270.52M 78.4M 2025-12